View of Arguments against Monitoring Levels of Anti-Factor Xa in Conjunction with Low-Molecular-Weight Heparin Therapy

Return to Article Details Arguments against Monitoring Levels of Anti-Factor Xa in Conjunction with Low-Molecular-Weight Heparin Therapy Download Download PDF